Navigation Links
Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox
Date:6/3/2009

r with Rotary Access Needle
  • Flexible Bipolar Hemostasis Forceps
  • Flexible Maryland Dissector
  • Articulating Hook Knife
  • Articulating Snare
  • Articulating Needle Knife
  • Articulating Graspers
  • Articulating Biopsy Forceps

    • The devices listed above will be used within an IDE trial approved by the FDA. The Adaptable Minimally-Invasive Surgical Platform and MAGS are limited to non-clinical applications at this time.

    About NOTES and SSL

    NOTES is an investigational approach to minimally invasive surgery, in which external incisions are eliminated, potentially leading to reduced pain, a quicker recovery and a faster return to normal activities for the patient. In NOTES, surgery can be performed through a natural orifice, eliminating the need for an external incision. To assist with visualizing the internal surgical site, an endoscope is passed through a natural orifice such as the mouth or vagina and then through an internal incision in the stomach, bladder, colon or uterus.

    Single-site laparoscopy (SSL) is another advanced form of minimally invasive surgery that enables surgeons to operate almost exclusively through a single entry point.

    About Ethicon Endo-Surgery

    Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology.

    Ethicon Endo-Surgery, Inc., is actively leading the development of NOTES through research to determine the most appropriate tools and technologies that may enable safe and effective NOTES surgery. The Et
    '/>"/>

    SOURCE Ethicon Endo-Surgery, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    1

    GOOD

    Page: 1 2 3 4

    Related medicine technology :

    1. Three Independent Studies Include the ImmuKnow(R) Assay to Manage and Optimize Immunosuppression Therapy in Transplant Patients
    2. New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
    3. VA Studies Advanced Prosthetic Arm
    4. PARI Pharmas Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS
    5. Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
    6. AlphaVax Announces Promising Results in Melanoma Studies
    7. Autism Studies Presented at Mid-Atlantic Research Consortium Meeting
    8. New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug
    9. New Studies on Once-Daily Extended Release Pramipexole Presented at American Academy of Neurology Annual Meeting
    10. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
    11. Studies Presented at AACR Annual Meeting Highlight Multiple Immunomodulatory Mechanisms of Peregrines PS-Targeting Antibodies

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/25/2009)...ordingtoMillenniumResearchGroup(MRG),theglobalauth...ly$3billionUSmarketfortraumafixationdeviceswillcon...erecenteconomicslowdown.MRG,s USMarketsforTraumaDe...hlydynamicoverthenextfiveyears,withcompetitorsintr...gmentsofthetraumafixationmarket,fuelingmarketgrowt...
    (Date:11/25/2009)...empraPharmaceuticalsInc.todayannouncedthatPrabhava...lpresentatthePiperJaffray21stAnnualHealthCareConfe...ceHotelinNewYorkCity.Dr.Fernandeswillprovideanover...ramsforthetreatmentofdrug-resistantpathogensinclud...Foundedin2006,CempraPharmaceuticalsisaprivately-he...
    (Date:11/25/2009)...ker.comannouncesthatanewmarketresearchreportisavai...-USMarketTrends&Analysis http://www.reportlin...ket-Trends--Analysis.html ,, TheUSintranasaldr...icapplicationsfromthedeliveryofconventionallocalth...ugs.Thefutureofthetechnologyhingesontotheeffective...
    Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 1Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 2Obama Speech Heralds Prevention Power of Screening Tests Like Colonoscopy 56843 3H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 56840 1H1N1 Swine Flu Preparedness Uncertainty Results in Higher Business Disruption Risk 56840 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 1Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 3
    ...uced risk of death by 13% (P=0.08), despite inclus...mara therapy , , - In a separate censored ana...o Femara, reduction in risk of death was 19% , ...IG 1-98 trial reinforces starting with Femara as t... , EAST HANOVER, N.J., Dec. 11 New long-term d...
    ...cember 11 AFFiRiS has started,pre-clinical develo... as,PD01, can be used to target a specific protein...s degenerative neurological disease. Excellent pro...ed the company to file a patent,application and pr...tive,results from external assessments impelled th...
    Other Medicine Technology:Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 2Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 3Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 4Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 5Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 6Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 7Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 8AFFiRiS Begins Development of a Parkinson's Vaccine 2AFFiRiS Begins Development of a Parkinson's Vaccine 3
    (Date:11/25/2009)...mice, disks placed under the skin kill tumor cells...althDay News) -- A cancer vaccine delivered in a f...in mice, a new study reports. , The method uses...are loaded with tumor-specific antigens and implan...to attack tumors. The Harvard University scientist...
    (Date:11/25/2009)... BioSpace.com, the premier r...unveiled the third edition of the BioForest™... Englewood, CO (Vocus) November 25, 2009 --...ce careers and information, unveiled the third edi...morning., , , , ,This regional campaign is a prom...
    (Date:11/25/2009)..., SALTLAKECITY,Nov.25/PRNewswire/--dazzlesmile,...C www.optimalhealthscience.com havefileda67-pagefe...azoogle.com,Inc.,JesseWillms,FarendServicesLimited...ththeUnitedStatesDistrictCourtfortheDistrictofUtah...gofdazzlesmile(TM)brandedteethwhiteningproducts,vi...
    (Date:11/25/2009)... HOUSTON - Two signaling pathways essential to nor... epidermal growth factor receptor (EGFR) pathways ...asion and metastasis, researchers from The Univers...n the Nov. 25 issue of Molecular Cell . , This ...naling components known to correlate with invasive...
    (Date:11/25/2009)...This press release is available in French . , ,...nologies are about to enter the marketplace, thank...imited Partnership (Univalor) and Cognitive Sensin... based in Montreal. , Univalor, which commercial... its affiliated institutions, and CSI have announc...
    Breaking Medicine News(10 mins):Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2
    ... 40%, to 56,000 new cases annually, CDC researcher...) -- The number of Americans newly infected with H...at was previously assumed, U.S.health officials ha..., Using the new method, researchers at the U.S. Ce...
    ...aw Firm Offers Assistance, Information to People A... Houston, TX (PRWEB) August 2, 2008 ...leman announce the launch of a http://www.tysabri...ysabri, a drug used to treat multiple sclerosis (M...
    ... new infections in 2006,follows nearly two-year de...w HIV infection,figures scheduled to be released o...and Prevention (CDC) are expected to increase the ...n ongoing,increase in the annual estimated infecti...
    ...Nasdaq: GXDX ), a specialized laboratory services... and Laurence R. McCarthy, Ph.D. to its Board of,D...am has been elected to,serve as a Class I director... elected to serve as a Class II director of,Genopt...
    ...ogram launched locally to help people manage the d...hospital admissions among participants. , The fir...s & Balances encourages people with diabetes to co...-cholesterol, an eye exam, and screening for kidne...
    ...ke reactions to nonionic iodinated contrast materi...nd can be treated safely with commonly used medica...earchers at the University of Michigan Hospitals i...st material to patients and some of these reaction...
    Other Medicine News:Health News:Number of New U.S. HIV Infections Gets Revised Upwards 2Health News:Tysabri Lawyers Pulaski & Middleman Launch Web Resource Center for Patients Suffering from Tysabri Side Effects 2Health News:New HIV Infection Figures from CDC to be Announced on Aug. 3 Underscore Need for National AIDS Strategy for the U.S. 2Health News:Genoptix Announces the Addition of New Members to Board of Directors 2Health News:Genoptix Announces the Addition of New Members to Board of Directors 3Health News:Innovative diabetes program in Bloomington-Normal, Ill., a success 2Health News:Allergic-like reactions to iodinated contrast material treated safely with commonly used medications 2
    Sterile Coil Packed Pediatric Suction Catheters with SAFE-T-VAC Valve
    Sterile Suction Catheters without Control Valve
    Sterile Single Loop Suction Catheters with TOUCH-TROL Valve
    Catheter Suction 14FR Sterile W/Control Valve
    Medicine Products: